The mIHC analysis (Fig. 8a) enabled simultaneous detection of tumor (CK7+) and immune (NKp46, PD-1, NKG2A) markers within the same tissue section, allowing precise distinction between tumor and immune components, particularly important in metastatic lesions, where infiltrates are dense and heterogeneous. This evidence concerns the gene NCR1 and neoplasm.